TP53 and cancer: Compared to well-known tumor suppressor genes or oncogenes such as TP53, MYC and PIK3CA, genes expressing components of the TM are neither frequently mutated, nor have homozygous (affecting both alleles) amplifications or deletions in TNBC or other cancer types (Figure 1a,b) [8].